duloxetine hydrochloride has been researched along with osteoprotegerin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hioki, T; Iida, H; Kim, W; Kozawa, O; Matsushima-Nishiwaki, R; Onuma, T; Tachi, J; Tanabe, K; Tokuda, H; Yamaguchi, S | 1 |
1 other study(ies) available for duloxetine hydrochloride and osteoprotegerin
Article | Year |
---|---|
Duloxetine suppresses BMP-4-induced release of osteoprotegerin via inhibition of the SMAD signaling pathway in osteoblasts.
Topics: 3T3 Cells; Animals; Bone Morphogenetic Protein 4; Cells, Cultured; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Mice; Osteoblasts; Osteoprotegerin; Signal Transduction; Smad1 Protein; Smad5 Protein; Smad8 Protein | 2021 |